BRCA1-treated BC cells were silenced by genistein therapy, which also caused GPR30 expression to be downregulated, Akt phosphorylation to be inhibited, B1 expression to be downregulated, and cell cycle arrest [178]. Here, AKT1 is linked to breast cancer.